Court Case Highlights Need For Continued Federal Protections

3410000930_95fc2866fa_zLast week, a US District Court blocked federal prosecutors from continuing a case against a medical marijuana cultivation company as a result of the current, albeit limited, congressional protections from the Department of Justice.

LA Weekly reported:

Humboldt County growers Anthony Pisarski and Sonny Moore had already pleaded guilty to federal allegations (conspiracy to manufacture and possess with intent to distribute) but sought an evidentiary hearing based on legislation, first enacted in 2014, that prohibits the U.S. Department of Justice from cracking down on cannabis suspects who are otherwise following their state laws. The Rohrabacher-Farr amendment is a budget rider, co-authored by SoCal U.S. Rep. Dana Rohrabacher, that prevents enforcement and prosecution in medical marijuana states by stripping funding for such endeavors.

U.S. District Court Judge Richard Seeborg on Tuesday stayed the prosecution, so the case is closed unless the Rohrabacher-Farr amendment expires and fails to be re-enacted and federal prosecutors want to resume their case. The defendants’ Beverly Hills attorney, Ronald Richards, says: “This is the first time in my 23-year career I’ve had a case stopped because of an appropriations rider.

“What the court did in this case may be used as a blueprint for other cases,” he says. “It opens the door for people not to get scared.”

In response to this verdict, California NORML Executive Director Dale Gieringer said, “It’s significant that a federal court ruled that people targeted by feds and in compliance with California’s medical marijuana laws ruled in the defendants’ favor.”

The Judge’s verdict was predicated on a previous ruling, United States v. McIntosh, a Ninth Circuit decision last year that upheld a medical marijuana defense for those facing federal prosecution in lawful medical states.

“This is the first case I’m aware of where McIntosh was cited and used to full effect,” continued Gieringer.

On July 27, Senator Patrick Leahy (D-VT) successfully offered and passed the Rohrabacher-Blumenauer amendment in the Senate Appropriations Committee to maintain this protection for lawful medical marijuana programs from the Department of Justice.

You can send a message to your Representative to support this language in the House by clicking HERE. 

 

Medical Marijuana Research Act of 2017

mj_researchRepresentatives Andy Harris, M.D. (R-MD-01), Earl Blumenauer (D-OR-03), H. Morgan Griffith (R-VA-09), and Zoe Lofgren (D-CA-19) introduced H.R. 3391: The Medical Marijuana Research Act of 2017.

This Act amends the federal law to facilitate clinical investigations involving the use of cannabis and cannabis-derived products.

As you may know, there are many benefits to medical cannabis. Those suffering from PTSD, Tourette’s Syndrome, Parkinson’s Disease, and many other debilitating conditions have found relief because of medical marijuana.  

But, despite the fact that over 200 million Americans now have legal access to some form of medical marijuana, present regulations make clinical investigations involving cannabis needlessly onerous. Passage of this measure would expedite federal reviews of clinical protocols, provide greater access to scientists who wish to study the drug, and mandate an FDA review of the relevant science.

Please click HERE to contact your Representative and urge him/her to support this important measure.

 

Washington State Responds To Attorney General Sessions’ Veiled Threats

Jeff_Sessions_(29299022521)As first reported by Tom Angell of MassRoots.com, Washington State Governor Jay Inslee and Attorney General Bob Ferguson responded to a July 24 letter from US Attorney General Jeff Sessions, in which Sessions’ made multiple allegations all based on a single misleading 2016 report.

One would say, they didn’t pull any punches:

“Your letter, citing the March 2016 Northwest High Intensity Drug Trafficking Area (NW HIDTA) report on marijuana in Washington, makes a number of allegations that are outdated, incorrect, or based on incomplete information.”

 

Cutting right to the heart of the matter, i.e. facts, the Washington state leaders again articulated their desire to educate the (seemingly willing) ignorant Sessions.

“We have twice requested an in-person meeting with you because we believe it will lead to better understanding than exchanging letters. If we can engage in a more direct dialogue, we might avoid this sort of miscommunication and make progress on the issues that are important to both of us. We therefore reiterate our request to meet with you, followed by further appropriate meetings between state and DOJ officials.”

 

One of the most basic functions of government is to simply provide consistency and certainty in law enforcement. So after repeated efforts by the state’s leadership to receive clarification, basic facets of the Department of Justice’s approach are still unknown. In yet another attempt for guidance, the Governor and state Attorney General requested information on:

  • Whether DOJ intends to follow recommendations from its Task Force on Crime Reduction and Public Safety—in particular, its reported recommendation to continue previous federal policy on state legalization of marijuana.
  • Whether President Trump’s previous statements of support for medical marijuana, and leaving recreational marijuana legalization to the states, represent the policy of the federal government.
  • Whether DOJ will support reasonable federal policies allowing financial institutions to provide service to licensed marijuana businesses, in order to avoid the public safety risks and transparency problems associated with all-cash businesses.
  • How state-regulated marijuana should be treated by the federal government following the President’s declaration that the opioid crisis constitutes a national emergency, and whether the federal government will support objective, independent research into the effects of marijuana law reform on opioid use and abuse.
  • Whether the federal government will help protect public health by supporting agricultural research on the safety of pesticides used in marijuana cultivation.
  • Whether the federal government will support research into expedited roadside DUI testing methods for law enforcement, as alternatives to blood draws.

 

How Attorney General Sessions will respond, only time will tell.

You can click HERE to send a message to your Representative to urge their support for The Respect State Marijuana Laws Act, bipartisan legislation to prevent the Department of Justice from enforcing federal prohibition in states that have chosen to legalize medical or adult-use marijuana.

You can view the full letter from Governor Inslee and AG Ferguson below:

Washington Officials Respond to Sessions Marijuana Letter by tomangell on Scribd

Setting the Record Straight

HumboldtOne of NORML’s primary missions is to move public opinion sufficiently to legalize the responsible use of marijuana by adults. One of the ways we successfully achieve this goal is by debunking marijuana myths and half-truths via the publication of timely op-eds in online and print media. Since the mainstream media seldom casts a critical eye toward many of the more over-the-top claims about cannabis, we take it upon ourselves to set the record straight.

The majority of NORML’s rebuttals are penned by Deputy Director Paul Armentano. In the past few weeks, he has published numerous op-eds rebuking a litany of popular, but altogether specious claims about the cannabis plant – including the contentions that cannabis consumption is linked to heart attacks, psychosis, violence, and a rise in emergency room visits and traffic fatalities, among other allegations.

Below are links to a sampling of his recent columns.:

Blowing up the big marijuana IQ myth — The science points to zero effect on your smarts

Blowing the lid off the ‘marijuana treatment’ racket

The five biggest marijuana myths and how to debunk them

It took just one distorted study for the media to freak out over health risks marijuana

Cannabis mitigates opioid abuse — the science says so

Three new marijuana myth-busting studies that the mainstream media isn’t picking up on

For a broader sampling of NORML-centric columns and media hits, please visit NORML’s ‘In the Media’ archive here.

If you see the importance of NORML’s educational and media outreach efforts, please feel free to show your support by making a contribution here.

SMART Bill Reintroduced in Congress

Congresswoman Suzan DelBene (D-WA-1)

Congresswoman Suzan DelBene (D-WA-1)

Congresswoman Suzan DelBene (D-WA-01) has reintroduced the State Marijuana And Regulatory Tolerance (SMART) Enforcement Act (H.R. 3534). This bill prohibits state-sanctioned marijuana consumers and businesses from being prosecuted by the federal government.

By a margin of more than 6 to 1, Americans say that individual states should be able to make their own laws governing the use and sale of marijuana. The SMART Enforcement Act acknowledges this voter sentiment while also ensuring states are operating in a safe and responsible manner.

In a prepared statement, Congresswoman DelBene says that her legislation “will fix the conflict between state and federal law by giving states effectively regulating marijuana themselves, such as Washington, a waiver from the Controlled Substances Act. It also resolves the banking issues currently forcing dispensaries to operate on an unsafe, all-cash basis. These waivers will ensure people in states that have different laws than the federal government on marijuana are protected from prosecution, provided they meet certain requirements, as more and more states work to regulate marijuana within their own borders.”

Legislation similar to this is pending in California, Assembly Bill 1578, to try and limit potential federal interference in the state’s marijuana regulatory laws. As Congresswoman DelBene said, “People in these states should not live in fear of the unpredictable actions of the Attorney General and Department of Justice.”

Click HERE to urge your Representatives to support this legislation.

Never Underestimate The Power Of A Single Face To Face Interaction

Legalize marijuanaCanadian Prime Minister Justin Trudeau is following through on his 2015 pledge to legalize and regulate the adult use of cannabis. Presently, Liberal Party backed legalization legislation is making its way through Parliament, which hopes to implement the new public policy by mid-2018.

But, as Toronto Star reporter Susan Delacourt writes, Trudeau was not always a supporter of marijuana policy reform. In fact, it wasn’t until he met face to face with NORML representatives that the Canadian Premiere ultimately changed his mind for good.

[Excerpt] When marijuana becomes legal in Canada next year, it will be mainly because Justin Trudeau had a change of mind in 2012.

… Five short years ago, Trudeau was not a fan of legalized pot. As he wandered around the 2012 Liberal policy convention in Ottawa — the same one in which a majority of party members voted in favour of legalization — Trudeau was a dissenting voice.

He told one interviewer that marijuana “disconnects you a little bit from the world” and that it was “not good for your health.” For those reasons alone, Trudeau said he wasn’t in favour of any measures that could make pot use more widespread.

“I don’t know that it’s entirely consistent with the society we’re trying to build,” Trudeau said in an interview that still lives on YouTube, where it’s immediately clear he hasn’t had his run-for-leadership makeover: he still sports a moustache and the long, unruly hair.

By the end of 2012, a lot of things had changed for Trudeau — beyond his appearance. He had changed his mind about running for Liberal leader, officially launching his campaign in October, and he was also starting to see that legalization was better than the decriminalization option he’d long favoured.

Today, Trudeau and his advisers trace the shift to a meeting with two women in his office in November of that year, who armed him with some of the pro-legalization arguments that he’s still using today — now, as prime minister. The two women were Kelly Coulter and Andrea Matrosovs, then representing what was known as the women’s alliance of the National Organization for the Reform of Marijuana Laws (NORML).

Coulter, who now lives in Victoria, remembers the meeting well, and is heartened to hear that Trudeau traces his conversion to this encounter.

“I actually saw the ‘aha’ moment,” Coulter says. It had been an emotional meeting in Trudeau’s tiny Parliament Hill office; the three of them talked about their own personal experience with marijuana. Trudeau talked about his mother using pot, and his brother, Michel, who had been charged with possession not long before he died. (Trudeau has subsequently told the story publicly of how his father used connections to get the charges dropped so that his son didn’t have a criminal record.)

Coulter told Trudeau flatly that decriminalization would not keep gangs and organized crime out of the marijuana business. “Al Capone would have loved it if alcohol had only been decriminalized,” she said — a line she often used when talking to politicians.

“I saw the light go on in his eyes,” Coulter said. “He was seeing this as a politician, realizing ‘I can sell this,’ ” she recalled.

Trudeau could see how this argument would blunt Conservative attacks on him as being soft on crime; with legalization, he could simultaneously seem liberal about marijuana but conservative about gangs and criminals. It helped persuade Trudeau that legalization, would be the best way for the government to regulate its use and keep it safe, especially for kids.

As we approach NORML’s upcoming National Conference and Lobby Day — taking place September 10-12 in Washington, DC — it is important to emphasize how influential a single face to face meeting with your elected officials can be. NORML’s interactions with lawmakers, whether its at town meetings or in the halls of Congress, are changing minds and shaping public policy.

Be part of the marijuana revolution. Get active. Get NORML.

Bill To Exclude Hemp From The Controlled Substances Act

hempfieldCongressman James Comer (R-KY-1) and 15 co-sponsors have reintroduced legislation to amend the federal Controlled Substances Act to exclude industrial hemp.

Currently, the Controlled Substances Act of 1970 labels hemp as a Schedule I drug.

H.R. 3530 excludes low-THC strains of cannabis grown for industrial purposes from the federal definition of marijuana.

The majority of US states have already enacted legislation redefining hemp as an agricultural commodity and allowing for its cultivation. In 2014, members of Congress approved language in the omnibus federal Farm Bill explicitly authorizing states to sponsor hemp research absent federal reclassification of the plant.

All parts of the hemp plant can be cultivated and used to produce everyday household items. It can be grown as a renewable source for raw materials such as clothing, paper, construction materials, and biofuel. Not only is it useful, but growing hemp is much more environmentally friendly than traditional crops.

According to the Congressional Research Service, the United States is the only developed nation in which industrial hemp is not an established crop.

Click HERE to urge your Representative to support this legislation.

 

Opioid Commission To Trump: Declare Emergency, Ignore Science

Per The New York Times:

WASHINGTON — President Trump’s commission on the opioid crisis asked him Monday to declare a national emergency to deal with the epidemic.

The members of the bipartisan panel called the request their “first and most urgent recommendation.”

Mr. Trump created the commission in March, appointing Gov. Chris Christie of New Jersey to lead it. The panel held its first public meeting last month and was supposed to issue an interim report shortly afterward but delayed doing so until now. A final report is due in October.

The initial recommendations are completely silent to the fact that medical marijuana access is associated with reduced rates of opioid use and abuse, opioid-related hospitalizations, opioid-related traffic fatalities, and opioid-related overdose deaths.

Chris Christie, sitting Governor of New Jersey until Jan. 17, 2018

Chris Christie, sitting Governor of New Jersey until Jan. 17, 2018

Over the last two months, over 8,000 voters contacted the Office of National Drug Control Policy commission, chaired by marijuana prohibitionist Chris Christie, with their personal stories and the relevant science to encourage the group to support medical marijuana as part of the approach to reduce the tragic effects of the opioid crisis. This effort was undertaken both by NORML and Marijuana Majority.

Governor Christie has zero percent credibility on drug policy, or any other policy, for that matter,” Erik Altieri, Executive Director of NORML said to Forbes of Christie at the time of his appointment to head the commission.

Nonetheless, this administration and Attorney General Jeff Sessions has continued to express skepticism with regard to the safety and efficacy of medical marijuana. Now, we now know that the President’s opioid commission is not interested in real solutions, but rather more empty rhetoric.

We have until October until the final report is to be issued.

Click here to send a message to the ONDCP commission to yet again tell them the facts and if you have one, please share your personal on how marijuana is a safer alternative to opioids. 

 

The Marijuana Justice Act Introduced In Senate

Senator Cory Booker (D-NJ)

Senator Cory Booker (D-NJ)

Senator Corey Booker (D-NJ) has introduced comprehensive marijuana reform legislation, the Marijuana Justice Act of 2017.

The bill would (1) remove marijuana from the US Controlled Substances Act, thereby ending the federal criminalization of cannabis; (2) incentivize states to mitigate existing and ongoing racial disparities in state-level marijuana arrests; (3) expunge federal convictions specific to marijuana possession; (4) allow individuals currently serving time in federal prison for marijuana-related violations to petition the court for resentencing; (5) and create a community reinvestment fund to invest in communities most impacted by the failed War on Drugs.

Click here to watch the video of Senator Booker discussing the bill.

“Not only is it imperative we end our failed experiment of marijuana prohibition, we must also ensure justice for those who suffered most under these draconian policies,” said NORML Executive Director Erik Altieri, “We applaud Senator Booker for introducing this robust legislation that would not only remove marijuana from the Controlled Substances Act, but provide a path forward for the individuals and communities that were most disproportionately targeted by our nation’s failed war on marijuana consumers.”

Thirty states, Washington, DC and the US territories of Guam and Puerto Rico have enacted legislation specific to the physician-authorized use of cannabis, while an estimated 63 million Americans now reside in jurisdictions where anyone over the age of 21 may possess cannabis legally. Voters overwhelmingly support these policy changes. According to a 2017 Quinnipiac University poll, 59 percent of Americans support full marijuana legalization and 71 percent believe that states, not the federal government, should set marijuana policy.

To date, these statewide regulatory programs are operating largely as voters and politicians intended. The enactment of these policies have not negatively impacted workplace safetycrime ratestraffic safety, or youth use patterns. They have stimulated economic development and created hundreds of millions of dollars in new tax revenue. Specifically, a 2017 report estimates that 123,000 Americans are now working full-time in the cannabis industry. Tax revenues from states like Colorado, Oregon, and Washington now exceed initial projections. Further, numerous studies have identified an association between cannabis access and lower rates of opioid useabusehospitalizations, and mortality.

017

 

Senate Committee Passes Amendment To Protect Medical Marijuana

Senator Patrick Leahy

Senator Patrick Leahy

Today, Senator Patrick Leahy (D-VT) successfully offered and passed the Rohrabacher-Blumenauer amendment in the Senate Appropriations Committee to protect lawful medical marijuana programs from the Department of Justice.

Initially enacted by Congress in 2014, the amendment maintains that federal funds cannot be used to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.” Last August, the Ninth Circuit Court of Appeals unanimously ruled that the language bars the federal government from taking legal action against any individual involved in medical marijuana-related activity absent evidence that the defendant is in clear violation of state law.

The decision to reauthorize the Rohrabacher-Blumenauer amendment language by the Senate committee illustrates both compassion and common sense when it comes to marijuana policy. Now, the majority of states and over 90 percent of the public approves of the use of marijuana as a medicine and Congress should not stand in the way of these reforms.

Whether or not the House of Representatives will take a vote on the amendment is unclear. They did not include its language in the version of the 2018 Commerce, Justice, Science (CJS) bill that passed the House Appropriations Committee earlier this month. Last year, the amendment passed on the floor of the House by a vote of 242-186.

Although the amendment was reauthorized by Congress in May as part of a short term spending package, US Attorney General Jeff Sessions has been aggressively lobbying leadership to ignore the provisions. President Trump also issued a signing statement objecting to the Rohrbacher-Blumenauer provision.

You can send a message to your Representative to support this language in the House by clicking HERE. 

 

Vote Expected Tomorrow On Medical Marijuana

Medical marijuanaTomorrow, the Senate Appropriations Committee will have to decide: Will they protect our nation’s 2 million lawful medical marijuana patients or subject them to the wrath of Attorney General Jeff Sessions?

The amendment they will be debating, known as Rohrabacher-Blumenauer, simply prevents the United States Department of Justice from spending any of our tax dollars enforcing federal marijuana prohibition against the 30 states which have now, or are in the process of, implementing a medical cannabis system.

Tell your Senators to protect patients by supporting the Rohrabacher-Blumenauer Amendment

There is NO moral reason to punish qualified patients and veterans from accessing marijuana for its therapeutic effects. Recently released data has revealed that the enactment of medical cannabis access is associated with lower rates of opioid abuse and mortality, and does not negatively impact workplace safety, teen use rates, or motor vehicle safety.

Yet, in a letter to members of Congress on May 1, Sessions demanded the end of Rohrabacher-Blumenauer, citing: “The Department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives.”

This is the delusional leadership we have coming out of the Justice Department. A man who equates those suffering from PTSD, cancer, AIDS, and other dire medical conditions to members of violent drug cartels.

We cannot allow Jeff Sessions to be the only one communicating with Congress. SEND A MESSAGE TO YOUR SENATORS NOW.

House Committee Blocks Veterans Equal Access Amendments

3410000930_95fc2866fa_zTwo weeks ago, the Senate Appropriations Committee voted 24-7 to include the Veterans Equal Access amendment, introduced by Senator Daines (R-MT) as part of the 2018 Military Construction, Veterans Affairs and Related Agencies Appropriations bill, which would expand much needed medical marijuana access to our nation’s veterans.

Yet House Rules Committee Chairman Pete Sessions (R-TX) decided that he did not want the full House to be able to vote on this critical amendment.

Rep. Earl Blumenauer (D-OR), the amendments lead sponsor, testified before the committee that it was “a critical area of literally life and death.”

Veterans are increasingly turning to medical cannabis as an effective alternative to opioids and other conventional medications to treat conditions like chronic pain and post-traumatic stress. A retrospective review of patients’ symptoms published in 2014 in the Journal of Psychoactive Drugs reported a greater than 75 percent reduction on a scale of post-traumatic symptom scores following cannabis therapy. This is why, in recent months, two of the largest veterans’ rights groups — AMVETS and the American Legion —  have resolved in favor of patients’ access to cannabis therapy.

Last year, majorities in both the US House and Senate voted to include similar language as part of the Fiscal Year 2017 MilCon-VA bill. However, Republicans sitting on the House Appropriations Committee elected to remove the language from the bill during a concurrence vote.

It is time that lawmakers stop playing politics with veterans’ health and pass and enact this amendment. There is still the possibility of the Senate’s amendment making it through the conference committee so make your voice heard.

You can send a message to your elected officials in support of veterans having access to medical marijuana by clicking HERE.

WATCH: Marijuana in the Halls of Congress

Yesterday, NORML moderated a Facebook Congressional Conversation on marijuana law reform with Representatives Earl Blumenauer, Tom Garrett, Beto O’Rourke, and Justin Amash.

We discussed a wide range of issues including the needless burden of the federal driver’s license suspension mandate, access to medical marijuana, racial injustice, and pending bipartisan legislation to remove cannabis from the Controlled Substances Act.

WATCH NOW:

Share on Facebook  |  Share on Twitter

The ongoing enforcement of cannabis prohibition financially burdens taxpayers, encroaches upon civil liberties, engenders disrespect for the law, impedes legitimate scientific research into the plant’s medicinal properties, and disproportionately impacts communities of color. Only when lawmakers speak honestly about the effects of prohibition and the senseless burdens it imposes on our communities will we be able to win substantial reform.

“At a time when 29 states and the District of Columbia have made the decision to regulate the sale and use of marijuana, we should rethink how the federal government approaches this drug. Our current approach to marijuana prevents legitimate medical use, fills our prisons with nonviolent offenders and continues to fuel drug violence,” said Representative Beto O’Rourke in a statement promoting the event.

In our continued effort to educate the lawmakers and the public, events like this will be able to open the eyes of those who have willfully ignored the issue.

NORML chapters throughout the country are working to advance legalization in state legislatures and, with your support, National NORML will continue to up the pressure in Washington, DC.

Click here to share the video through your networks and support efforts like this in the future. 

 

Uruguay: Retail Cannabis Sales Begin Today

Select pharmacies in Uruguay are now dispensing marijuana to adults, under regulations that went into effect today.

Sixteen pharmacies are presently licensed to engage in cannabis sales, and some 5,000 adults so far have registered with the state to purchase marijuana products — which are capped at a price of $1.30 per gram.

Sales to foreign tourists are not permitted under the law.

Federal officials initially approved legislation in 2013 lifting Uruguay’s criminal prohibition of the plant. Under the policy change, citizens may cultivate up to six plants per household, and engage in collective cultivation as part of membership clubs. Rules and regulations governing the distribution of marijuana for medical purposes are overseen by the Ministry of Public Health.

Tell AAA To Stop Lying About Legalization

majority_supportOver the first six months of 2017, the American Automobile Association (aka AAA) has been spreading misinformation and propaganda in a lobbying effort to defeat marijuana legalization legislative efforts in Connecticut, Delaware, Maryland, and other states.

As reported by Leafly.com, AAA representatives have recently preyed upon unsubstantiated fears regarding the alleged “increased plague of drugged driving” and the claim that “more babies will be born high” on marijuana in their lobbying efforts against adult use regulatory reforms. The distortions do nothing to advance the public debate surrounding legalization, but they do tarnish the organization’s reputation.

Send a message to AAA telling them to put the brakes on lobbying against legalization efforts

According to federal data, auto accident fatalities have fallen significantly over the past two decades – during the same time that a majority of US states have legalized marijuana for either medical or social use. In 1996 when California became the first state to legalize medical marijuana, the US National Highway Traffic Safety Administration reported that there were an estimated 37,500 fatal car crashes on US roadways. This total fell to under 30,000 by 2014.

Further, a recently published study in the American Journal of Public Health reports that fatal traffic accident rates in legal marijuana states are no different than those in states where cannabis remains illegal. A separate study published last year in the same journal previously reported that the enactment of medical marijuana legalization laws is associated with a reduction in traffic fatalities compared to other states, particularly among younger drivers.

One would hope that AAA would be nonpartisan in this debate; that they would be the group to separate the facts from the myths so that politicians and law enforcement would be more likely to pursue evidence-based policies with regard to regulating marijuana in a manner that strengthens public safety. Instead they’re largely fear-mongering and further politicizing the issue — calling for the continued criminalization and arrest of millions of Americans who choose to use marijuana privately and responsibly. By doing so, they are arguing in favor of the failed criminal justice policies of the past and they are alienating the 60 percent of Americans who endorse the outright legalization of recreational cannabis by adults (Gallup, 2016).

Tell AAA to stop distorting the truth, send their public affairs department a message right now

There are areas of public policy where AAA is absolutely in agreement with reform advocates, including NORML. For instance, we both agree that driving under the influence of cannabis should be discouraged and legally prohibited, and that the detection of either THC or its metabolites in blood or urine is not indicative of psychomotor impairment and, therefore, should not be used a legal standard of criminal liability.

Our hope is that some day groups like NORML and AAA can work together to advocate for rational policies that work to keep our roadways safe from the threat of impaired drivers. Specifically, we recognize — as does AAA — that there is a need for greater tools and methods  to more accurately determine whether or not someone is under the influence of cannabis, such as via the use and promotion of handheld performance technology.

Tell AAA that the days of ‘reefer madness’ are over. It’s time for a rational and evidence-based discussion regarding how best to regulate the use of marijuana by adults and how to keep our roads safe.

Login | Register

Copyright Top Nug © All Rights Reserved · Top Nug Theme by Ame

PIXSELL8 Pixel Count Remaining